Furthermore, there was a female-specific effect of MMP10 on cognitive and functional decline in AD patients, suggesting that MMPs and TIMPs could be useful biomarkers for sex differences and progression in AD [266]. This evidence concerns the gene MMP10 and Alzheimer disease.